Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $4.83 -0.89 (-15.56%) Closing price 04/4/2025 04:10 PM EasternExtended Trading$4.81 -0.02 (-0.39%) As of 04/4/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.69Holdings in PILL have an aggregate rating of Moderate Buy based on 373 analyst ratings issued in the past year covering 43 companies (81.0% of the portfolio).PILL Aggregate Price Target$4.83High Prediction$4.83Average Prediction$4.83Low Prediction$4.83Holdings in PILL have an aggregate price target of $4.83 and a range of $4.83 to $4.83 covering 43 companies (81.0% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.13%CORTCorcept Therapeutics$74.45-6.2%4.2977 of 5 stars3.00$143.25 92.4%5Analyst ForecastInsider TradeOptions VolumeAnalyst RevisionNews CoverageGap DownHigh Trading Volume3.06%TARSTarsus Pharmaceuticals$47.02-5.1%2.7254 of 5 stars3.00$63.67 35.4%7Positive NewsGap Down3.06%LLYEli Lilly and Company$737.56-6.5%4.8991 of 5 stars2.84$1,009.72 36.9%19Gap Down3.04%RPRXRoyalty Pharma$31.11-2.1%4.5388 of 5 stars3.00$41.60 33.7%6Positive NewsHigh Trading Volume2.99%ELANElanco Animal Health$9.17-5.7%3.9112 of 5 stars2.43$15.17 65.5%7News CoverageGap Down2.98%AXSMAxsome Therapeutics$98.86-8.4%4.6257 of 5 stars3.00$167.64 69.6%15Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap Down2.98%JAZZJazz Pharmaceuticals$110.04-8.9%4.815 of 5 stars2.93$187.71 70.6%14Insider TradePositive NewsGap DownHigh Trading Volume2.96%ITCIIntra-Cellular Therapies$131.873.4679 of 5 stars2.33$106.23 -19.4%15Analyst ForecastNews CoveragePositive News2.95%ZTSZoetis$151.76-4.9%4.4782 of 5 stars3.08$215.90 42.3%12Positive NewsGap Down2.93%PFEPfizer$22.99-5.4%4.9646 of 5 stars2.63$31.92 38.9%16High Trading Volume2.92%JNJJohnson & Johnson$153.03-4.3%4.5211 of 5 stars2.56$171.33 12.0%18Analyst ForecastOptions VolumeHigh Trading Volume2.92%BMYBristol-Myers Squibb$55.32-4.3%3.7167 of 5 stars2.33$57.86 4.6%18Short Interest ↑Analyst RevisionPositive News2.92%PRGOPerrigo$26.31-2.2%4.9197 of 5 stars2.25$33.00 25.4%4Short Interest ↓News CoveragePositive NewsGap DownHigh Trading Volume2.90%OGNOrganon & Co.$13.04-9.8%4.6575 of 5 stars2.43$20.80 59.6%7Positive NewsGap Down2.86%VTRSViatris$7.62-6.6%2.5239 of 5 stars1.75$10.50 37.8%4High Trading Volume2.86%PBHPrestige Consumer Healthcare$82.85-2.0%4.0044 of 5 stars2.50$93.33 12.7%6Positive NewsHigh Trading Volume2.78%MRKMerck & Co., Inc.$81.48-5.7%5 of 5 stars2.65$117.12 43.7%23Analyst RevisionHigh Trading Volume2.52%EWTXEdgewise Therapeutics$11.51-15.2%1.9777 of 5 stars2.75$40.38 250.8%8Analyst ForecastInsider TradeOptions VolumeAnalyst RevisionNews CoverageGap DownHigh Trading Volume2.26%HRMYHarmony Biosciences$29.26-5.5%4.2515 of 5 stars3.00$53.33 82.3%9Gap Down2.24%PCRXPacira BioSciences$23.10-4.9%3.4058 of 5 stars2.33$27.22 17.8%9Gap Down2.09%AMPHAmphastar Pharmaceuticals$26.61-2.3%4.0731 of 5 stars2.00$43.50 63.5%3Gap Down1.85%ARVNArvinas$6.56-4.9%3.6314 of 5 stars2.67$35.50 441.2%15Positive NewsGap DownHigh Trading Volume1.63%SUPNSupernus Pharmaceuticals$32.74+0.8%1.9906 of 5 stars2.33$36.00 10.0%3Analyst UpgradeShort Interest ↓News CoverageGap DownHigh Trading Volume1.57%HROWHarrow$23.52-2.2%2.1934 of 5 stars3.00$60.50 157.2%4Analyst ForecastAnalyst RevisionNews CoverageGap Down1.51%ANIPANI Pharmaceuticals$67.52-1.1%3.4527 of 5 stars3.00$79.75 18.1%9Positive NewsHigh Trading Volume1.39%COLLCollegium Pharmaceutical$28.14-3.0%4.0049 of 5 stars2.80$43.60 54.9%51.39%LQDALiquidia$12.90-8.7%2.3556 of 5 stars3.11$26.63 106.4%9Gap DownHigh Trading Volume1.38%LGNDLigand Pharmaceuticals$99.57-3.4%4.2731 of 5 stars3.00$147.00 47.6%6Short Interest ↑Positive NewsGap Down1.13%WVEWave Life Sciences$6.03-9.2%4.494 of 5 stars3.00$22.60 274.8%10High Trading Volume1.11%INVAInnoviva$17.72-2.0%4.3005 of 5 stars3.00$55.00 210.4%2Analyst DowngradeNews CoveragePositive News1.08%AMRXAmneal Pharmaceuticals$7.38-5.5%2.6105 of 5 stars3.00$10.80 46.3%5News CoverageGap Down0.85%MNMDMind Medicine (MindMed)$5.43-2.2%2.0374 of 5 stars3.23$25.11 362.5%13Gap Down0.83%EOLSEvolus$10.69-6.1%3.7697 of 5 stars3.00$24.67 130.7%4High Trading Volume0.80%XERSXeris Biopharma$4.41-9.6%4.2132 of 5 stars2.80$6.10 38.3%5Positive NewsGap DownHigh Trading Volume0.76%OCULOcular Therapeutix$6.36-9.1%3.0926 of 5 stars2.88$16.38 157.5%8News Coverage0.73%OMEROmeros$7.06-4.1%3.3989 of 5 stars2.80$22.50 218.7%5Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Down0.64%CRMDCorMedix$5.86-3.9%2.4263 of 5 stars3.13$15.14 158.4%8Analyst UpgradeGap Down0.62%ESPREsperion Therapeutics$1.23-4.7%3.6033 of 5 stars2.50$6.75 448.8%60.56%NUVBNuvation Bio$1.661.5923 of 5 stars3.25$8.75 427.1%4High Trading Volume0.54%EYPTEyePoint Pharmaceuticals$4.61-7.6%1.5126 of 5 stars3.00$26.63 477.5%9Positive NewsGap Down0.52%ELVNEnliven Therapeutics$18.69-6.7%2.4551 of 5 stars3.20$38.75 107.3%5Gap Down0.42%PAHCPhibro Animal Health$19.19-5.1%3.6971 of 5 stars1.50$21.00 9.4%4News CoveragePositive NewsGap Down0.38%ZVRAZevra Therapeutics$7.04-5.2%2.6002 of 5 stars3.11$22.29 216.6%9Positive News This page (NYSEARCA:PILL) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PILL Stock Free PILL Stock Alerts